Doximity, Inc.
NYSE:DOCSMedical - Healthcare Information Services
-$0.09 today
- Market cap
- $5.47B
- Beta
- 1.29
- P/E (TTM)
- 19.2
- EPS (TTM)
- $1.06
Volume 2.27M
Average 3.89M
DOCS Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Doximity, Inc.NYSE: DOCS
Other Income / Expenses · Q2 FY2027 · quarter ended Sep 2026
Other income / expenses declines year over year
Q2 FY2027 other income / expenses of $6.41M fell 30.8% year over year, behind the -23.9% change in trailing-twelve-month other income / expenses. Sequentially, it fell 4.7% from the prior quarter. Over 3 fiscal years it compounded at +63.4% a year.
Context
- Other income / expenses amounted to 5.4% of revenue in FY2026, down 0.8 pp from a year earlier.
- Other income / expenses increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -30.8% toward the trailing-twelve-month pace of -23.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2026
- 35.09M USD
- Year-over-year change
- -1.9%
- 4-year CAGR
- +194.1%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 35.09M | -1.9% |
| FY2025 | 2025-03-31 | 35.77M | +67.8% |
| FY2024 | 2024-03-31 | 21.32M | +165.0% |
| FY2023 | 2023-03-31 | 8.05M | +1616.0% |
| FY2022 | 2022-03-31 | 469K | — |
Other Income / Expenses vs competitors
How DOCS compares with its peers on the latest reported figures
- DOCS's LTM Sep 2026 other income / expenses of $29.32M is the 2nd highest of the 10 companies compared; the peer median is -$89.1M.
- Its year-over-year change of -23.9% is the 8th highest of 10, against a peer median of +16.7%.
- Other income / expenses amounts to 4.4% of revenue for DOCS, versus a peer median of 2.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $41.85M | +674.3% | — | 2.8% | |
| LTM Sep 2026 | $29.32M | -23.9% | +63.4% | 4.4% | |
| LTM Sep 2026 | $18.14M | -59.5% | — | 1.4% | |
| LTM Jul 2026 | -$40.16M | +65.3% | — | 2.9% | |
| LTM Jul 2026 | -$82.2M | +33.0% | — | 1.9% | |
| LTM Jun 2026 | -$89.1M | +16.7% | — | 1.4% | |
| LTM Jul 2026 | -$98.08M | -19.7% | — | 3.4% | |
| LTM Jun 2026 | -$381M | +16.4% | — | 4.6% | |
| LTM Jun 2026 | -$419.89M | -117.3% | — | 5.1% | |
| LTM Jun 2026 | -$574.9M | +49.9% | — | 3.9% | |
| Peer median (excluding DOCS) | -$89.1M | +16.7% | — | 2.9% | |
Competitors are the stored peer set for DOCS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 343.55M | 419.05M | 475.42M | 570.4M | 644.86M |
| Cost of Revenue | 39.79M | 53.49M | 50.67M | 55.87M | 70.33M |
| Gross Profit | 303.76M | 365.56M | 424.75M | 514.53M | 574.54M |
| Gross Margin | 88.4% | 87.2% | 89.3% | 90.2% | 89.1% |
| Research & Development | 62.35M | 80.19M | 81.98M | 93.04M | 130.7M |
| Selling, General & Admin | 127.88M | 160.27M | 170.96M | 191.38M | 228.92M |
| Operating Expenses | 190.23M | 240.45M | 260.88M | 286.73M | 359.62M |
| Depreciation & Amortization | 5.04M | 10.28M | 10.27M | 10.66M | 14.38M |
| EBITDA | 119.05M | 143.44M | 182.08M | 240.76M | 264.39M |
| EBITDA Margin | 34.7% | 34.2% | 38.3% | 42.2% | 41.0% |
| Operating Income | 113.54M | 125.11M | 163.88M | 227.8M | 214.92M |
| Operating Margin | 33.0% | 29.9% | 34.5% | 39.9% | 33.3% |
| Interest Income | 2.15M | 9.29M | 21.66M | 35.85M | 35.7M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 469K | 8.05M | 21.32M | 35.77M | 35.09M |
| Income Before Tax | 114.01M | 133.16M | 185.2M | 263.57M | 250.01M |
| Pre-Tax Margin | 33.2% | 31.8% | 39.0% | 46.2% | 38.8% |
| Income Tax Expense | (40.78M) | 20.34M | 37.62M | 40.39M | 53.95M |
| Net Income | 154.78M | 112.82M | 147.58M | 223.19M | 196.05M |
| Net Margin | 45.1% | 26.9% | 31.0% | 39.1% | 30.4% |
| EPS (Basic) | 0.81 | 0.58 | 0.78 | 1.19 | 1.05 |
| EPS (Diluted) | 0.70 | 0.53 | 0.72 | 1.11 | 0.98 |
| Weighted Avg Shares | 163.48M | 193.18M | 190.17M | 186.84M | 187.01M |
| Weighted Avg Shares (Diluted) | 191.02M | 213.43M | 205.73M | 201.21M | 199.05M |
Doximity, Inc.
NYSE:DOCS
Intrinsic Alpha fair value
Locked
Current Price
$30.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.